Altan Ozgit

Altan Ozgit serves as CEO at Mega-Farma İlaç Sanayi. Mega-Farma İlaç Sanayi operates in the pharmaceuticals sector with approximately 45.0 employees. The company is headquartered in Istanbul, Istanbul.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 1,026 executive contacts are available in Istanbul.
• • Our database includes 201,464 c suite-level executives.

WordPress.org Google Font API Mobile Friendly Android Flutter Remote

pharmaceutical manufacturing food supplements healthcare products dermatology treatments joint care supplements cosmetic products natural remedies skin care organic solutions anti-aging skin care collagen supplements anti-inflammatory products oral care woman's health solutions biodisidal products safety & quality certifications youthful skin solutions vitamins & minerals probiotic supplements arthritis treatments tendon support products eczema treatments acne solutions rosacea treatments psoriasis treatments stress relief supplements nutritional health sustainable health solutions wellness products skin restorative treatments oral hygiene products anti-aging formulas skin hydration treatment for oral diseases glucosamine supplements essential oils dietary supplements natural skin remedies beauty care dental health wellness coaching female health management tendonitis treatment natural body care safety in production health awareness campaigns research-based solutions chronic illness support pharmaceuticals medical health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Altan Ozgit in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Mega-Farma İlaç Sanayi.

Altan Ozgit's Position in the MessageCEO Database

• •Altan Ozgit is 1 of 1 verified executive contact we track at Mega-Farma İlaç Sanayi.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •1,019 verified executive contacts in Istanbul are in the database.
• •10 verified contacts work at pharmaceuticals companies in the 45.0 employee range (same size as Mega-Farma İlaç Sanayi).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Altan Ozgit directly?

Altan Ozgit's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Mega-Farma İlaç Sanayi. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Altan Ozgit work for?

Altan Ozgit is CEO at Mega-Farma İlaç Sanayi, a company in the pharmaceuticals sector with 45.0 employees. The company is based in Istanbul, Istanbul.

Can I pitch or sell to Altan Ozgit?

As CEO at Mega-Farma İlaç Sanayi, Altan Ozgit is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Altan Ozgit directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Altan Ozgit in?

Altan Ozgit works in the pharmaceuticals industry as CEO at Mega-Farma İlaç Sanayi. MessageCEO provides verified contact information for executives across all major industries.

Is Altan Ozgit's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Altan Ozgit's profile is kept up-to-date with the latest available information.

Last updated: November 15, 2026